B/F/TAF Tied To High Rates Of Viral Suppression In Patients With HIV, Substance Abuse Disorder, Research Finds

Infectious Disease Advisor (3/28, Nye) reports a study suggests that “bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is associated with high rates of initial virologic suppression among patients with HIV infection and substance use disorder at...